With many pharmaceutical companies focusing on lifestyle drugs, there is a growing trend toward prophylactic drugs that work by decreasing the frequency of symptom onset, especially for conditions such as migraine headaches, asthma, or chronic back pain.Botulinum toxin is expected to drive the development of a new class of prophylactic, local drugs that answer the patient's need for reduced medica